Quick Answer
Mereo BioPharma Group plc reported Total Assets of $45.92 million for the year ending 2025.
- Mereo BioPharma Group plc showed a decrease of -39.9% in Total Assets from 2024 to 2025.
- This data is from Mereo BioPharma Group plc's annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: $55.94 million | Q2 2024: $96.13 million | Q3 2024: $88.75 million | Q1 2025: $68.32 million | Q2 2025: $62.63 million | Q3 2025: $53.60 million.
- Over the full 8 years of available data (2018 to 2025), Mereo BioPharma Group plc's Total Assets has declined by 31.7%.
- Historical annual values: Fiscal year 2025: $45.92 million | Fiscal year 2024: $76.39 million | Fiscal year 2023: $66.50 million | Fiscal year 2022: $77.41 million | Fiscal year 2021: $126.42 million | Fiscal year 2020: $62.95 million | Fiscal year 2019: $86.45 million | Fiscal year 2018: $67.28 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: